Atossa Therapeutics, Inc.
$2.58
-0.06 (-2.27%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +17.8%
- 3 Months
- -50.7%
- YTD
- -70.8%
- 1 Year
- -77.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 87.3%
- Largest decline max drawdown, since Aug 2025
- -90.1%
- Risk-adjusted return Sharpe ratio, 1-year
- -1.20
Own ATOS?
See how ATOS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.